US Food and Drug Administration approved the drug Prolia (denosumab) for the treatment of osteoporosis in postmenopausal women at high risk of fractures as well as for the treatment of bone tissue loss in men, prostate cancer patients with similar risk.

Clinical studies have shown that Denosumab works by improving bone mineral density and reducing different types of fractures.

Natazia is a new oral contraceptive that has been recently approved by FDA. Natazia is made by the pharmaceutical company Bayer HealthCare Pharmaceuticals. Natazia is currently available in the European Union under the name Qlaira. Natazia is the first four-phase oral contraceptive that releases female sex hormone progestin at four times for twenty eight day in treatment cycle. Natazia contains 2 active active ingredients: estrogen (estradiol valerate) and progestin (dienogest).

According to a new study conducted in Finland, smoking during pregnancy can cause mental problems in the children.
It is well known that if a woman smokes during pregnancy, it can lead to a large amount of congenital diseases including respiratory diseases such as asthma, heart and blood vessels diseases, high risk of ENT infections and other health problems. The new study was focused on the relationship of mental health problems such as depression, attention deficit and hyperactivity disorder (ADHD) and maternal smoking during pregnancy.

Study: Can the drug for osteoporosis treatment prevent breast cancer in high-risk group?

Evista has advantages for women of increased risk group during menopause. Results of a large, national studies have shown that Evista is equivalent to other well-recognized preventive means – tamoxifen in order to prevent breast cancer among women at increased risk during menopause. Moreover, Evista as it turned out, has less side effects in view of uterine cancer and clotting problems, comparing with women who administer tamoxifen.

Children autism

According to extensive research conducted in the United States, a mature age of the mother increases the risk of autism in a child, regardless of age of his father.

Scientists have shown that increasing maternal age by 5 years is associated with increased risk of autism in children by 18%. Thus, for a woman who became a mother at the age of 40 years, the risk of birth of child with autism is 100% higher than in women in 25 years of age.